Nisa Investment Advisors’s Ginkgo Bioworks DNA Stock Holding History

Nisa Investment Advisors’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.7K	Buy	+3,100	New	+$25.9K	﹤0.01%	2052
2025 Q4	–	Sell	-36	Closed	-$525	–	2997
2025 Q3	$525	Buy	+36	New	+$431	﹤0.01%	2853
2024 Q1	–	Sell	-75	Closed	-$5.07K	–	2805
2023 Q4	$5.07K	Sell	75 -4,950	-99%	-$303K	﹤0.01%	2120
2023 Q3	$364K	Hold	5,025	–	–	﹤0.01%	1162
2023 Q2	$374K	Buy	5,025 +4,505	+866%	+$267K	﹤0.01%	1158
2023 Q1	$28K	Hold	520	–	–	﹤0.01%	1898
2022 Q4	$35K	Sell	520 -6,980	-93%	-$642K	﹤0.01%	1881
2022 Q3	$936K	Buy	+7,500	New	+$894K	0.01%	827

Other funds holding DNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

PGCM

Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Nisa Investment Advisors's DNA Position: Q2 2026 in Review

Nisa Investment Advisors opened a new position in Ginkgo Bioworks (DNA) in Q2 2026: 3,100 shares worth $30.7K. The stake represents ﹤0.01% of the portfolio and ranks #2052 among its holdings. This is a return to the name: Nisa Investment Advisors previously reported a position in DNA as recently as Q3 2025.

Nisa Investment Advisors first reported a position in DNA in Q3 2022 and has held it in 8 quarters since. The position peaked at $936K in Q3 2022. 73 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

Nisa Investment Advisors held 3,100 shares of Ginkgo Bioworks worth $30.7K as of Q2 2026.
Ginkgo Bioworks was a new Nisa Investment Advisors position in Q2 2026.
Ginkgo Bioworks made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2052 holding.
Nisa Investment Advisors first reported a position in Ginkgo Bioworks in Q3 2022 and has held it in 8 quarters since.
Nisa Investment Advisors's Ginkgo Bioworks position peaked at $936K in Q3 2022.
73 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.